UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis

PloS one, 2012-03, Vol.7 (3), p.e33236

2012

Volltextzugriff (PDF)

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study

European journal of clinical pharmacology, 2015-12, Vol.71 (12), p.1525-1533

2015

Volltextzugriff (PDF)

Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults

PloS one, 2014-03, Vol.9 (3), p.e92061

2014

Volltextzugriff (PDF)

Healthcare costs of adverse drug reactions and potentially inappropriate prescribing in older adults: a population-based study

BMJ open, 2022-09, Vol.12 (9), p.e062589-e062589

2022

Volltextzugriff (PDF)

Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications?

PloS one, 2015-09, Vol.10 (9), p.e0137451-e0137451

2015

Volltextzugriff (PDF)

Comparing regulatory guidance on risk minimization/mitigation and the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies checklist

British journal of clinical pharmacology, 2024-09

2024

Volltextzugriff (PDF)

An observational post‐authorization safety study (PASS) of naloxegol drug utilization in four European countries

Pharmacoepidemiology and drug safety, 2024-01, Vol.33 (1), p.e5710-n/a

2024

Volltextzugriff (PDF)

Preventable drug related mortality in a Swedish population

Pharmacoepidemiology and drug safety, 2010-02, Vol.19 (2), p.211-215

2010

Volltextzugriff (PDF)

Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005‐2015 show improved survival over time

European journal of haematology, 2019-09, Vol.103 (3), p.190-199

2019

Volltextzugriff (PDF)

Prevalence, nature and potential preventability of adverse drug events – a population‐based medical record study of 4970 adults

British journal of clinical pharmacology, 2014-07, Vol.78 (1), p.170-183

2014

Volltextzugriff (PDF)

Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study

BMJ open diabetes research & care, 2022-01, Vol.10 (1), p.e002363

2022

Volltextzugriff (PDF)

Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden

Multiple sclerosis and related disorders, 2021-02, Vol.48, p.102694-102694, Article 102694

2021

Volltextzugriff (PDF)

Comparing Methods for Estimating Direct Costs of Adverse Drug Events

Value in health, 2017-12, Vol.20 (10), p.1299-1310

2017

Volltextzugriff (PDF)

The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses’ reporting

European journal of clinical pharmacology, 2015-05, Vol.71 (5), p.631-636

2015

Volltextzugriff (PDF)

Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based study

Pharmacoepidemiology and drug safety, 2013-12, Vol.22 (12), p.1317-1325

2013

Volltextzugriff (PDF)

Modelling drug-related morbidity in Sweden using an expert panel of physicians

European journal of clinical pharmacology, 2012-09, Vol.68 (9), p.1309-1319

2012

Volltextzugriff (PDF)

Pharmacoepidemiology at Nordic School of Public Health NHV: Examples from 1999 to 2014

Scandinavian journal of public health, 2015-08, Vol.43 (16_suppl), p.73-80

2015

Volltextzugriff (PDF)

Direct and indirect costs for adverse drug events identified in medical records across care levels, and their distribution among payers

Research in social and administrative pharmacy, 2017-11, Vol.13 (6), p.1151-1158

2017

Volltextzugriff (PDF)

INFORM – Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden (P8-4.009)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Modelling drug-related morbidity in Sweden using an expert panel of pharmacists

International journal of clinical pharmacy, 2012-08, Vol.34 (4), p.538-546

2012

Volltextzugriff (PDF)

Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults

PloS one, 2013-09, Vol.8 (9), p.e73166

2013

Volltextzugriff (PDF)

Descriptive analysis of multiple myeloma patients in a real-world setting from the Finnish Hematology Registry

International journal of clinical and experimental medicine, 2024, Vol.17 (2), p.19-30

Tskhvarashvili, Giorgi

2024

Volltextzugriff (PDF)

Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden

Multiple sclerosis and related disorders, 2022-03, Vol.59, p.103572, Article 103572

2022

Volltextzugriff (PDF)

Drug Prices in Finland

Pharmaceutical Prices in the 21st Century, 2014, p.93-112

2014

Volltextzugriff (PDF)

Emissions from modern engines induce distinct effects in human olfactory mucosa cells, depending on fuel and aftertreatment

The Science of the total environment, 2023-12, Vol.905, p.167038, Article 167038

2023

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(19)
Humans
(18)
Female
(14)
Aged
(11)
Male
(11)
Medicin Och Hälsovetenskap
(11)
Middle Aged
(10)
Pharmacology & Pharmacy
(10)
Adult
(9)
Drug-Related Side Effects And Adverse Reactions - Epidemiology
(8)
Cohort Studies
(7)
Medical Records
(7)
Side Effects
(7)
Sweden - Epidemiology
(7)
Young Adult
(7)
Adolescent
(6)
Folkhälsovetenskap, Global Hälsa, Socialmedicin Och Epidemiologi
(6)
Medicine
(6)
Pharmacology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study

Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults

Healthcare costs of adverse drug reactions and potentially inappropriate prescribing in older adults: a population-based study

Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications?

Comparing regulatory guidance on risk minimization/mitigation and the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies checklist

An observational post‐authorization safety study (PASS) of naloxegol drug utilization in four European countries

Preventable drug related mortality in a Swedish population

Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005‐2015 show improved survival over time

Prevalence, nature and potential preventability of adverse drug events – a population‐based medical record study of 4970 adults

Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study

Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden

Comparing Methods for Estimating Direct Costs of Adverse Drug Events

The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses’ reporting

Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based study

Modelling drug-related morbidity in Sweden using an expert panel of physicians

Pharmacoepidemiology at Nordic School of Public Health NHV: Examples from 1999 to 2014

Direct and indirect costs for adverse drug events identified in medical records across care levels, and their distribution among payers

INFORM – Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden (P8-4.009)

Modelling drug-related morbidity in Sweden using an expert panel of pharmacists

Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults

Descriptive analysis of multiple myeloma patients in a real-world setting from the Finnish Hematology Registry

Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden

Drug Prices in Finland

Emissions from modern engines induce distinct effects in human olfactory mucosa cells, depending on fuel and aftertreatment

Suchergebnisse filtern